Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Coloplast shares surge as Danish medtech group delivers strong Q1

(Sharecast News) - Danish medical device group Coloplast saw shares surge over 8% in Copenhagen on Friday after the company delivered high single-digit growth across all areas of the business in the first quarter. Organic revenues were up 8% in the three months to 31 December, in line with Coloplast's full-year growth rate guidance, while earnings before interest and tax gained 3% to DKK 1.82bn.

Organic revenues in the Ostomy Care business rose 8%, Continence Care increased 8%, Voice and Respiratory Care was up 7%, Advanced Wound Care rose 9% while Interventional Urology improved by 5%.

Meanwhile, biologics woundcare firm Kerecis was acquired last August for DKK 8.9bn ($1.3bn) made a strong start to the new financila year and saw underlying growth in the first quarter of 35% on the back of market share gains.

The company said it continues to expect 8% organic growth over the full year to 30 October 2024, but that reported growth in Danish krone has been trimmed to 11% from 12% previously due to negative currency movements. Meanwhile, Kerecis is estimated to account for four percentage points to group revenue growth over the full year.

Chief executive Kristian Villumsen said the company delivered a "good start", saying: "I want to highlight a strong first quarter in our Chronic Care business, which delivered broad-based growth, as well as a good start to the year for our newest member of the Coloplast family, Kerecis."

Villumsen continued: "We have now kicked off a year of product launches that will help drive our future growth. This quarter, we are launching Biatain Silicone Fit for pressure injury prevention and wound management in the US, as well as Peristeen® Light for people with bowel disorders in Europe. I believe both products will make a significant difference to people living with intimate healthcare needs."

The stock was up 8.2% at kr 878.8 by 1223 CET.

Share this article

Related Sharecast Articles

Huddled Group buys Food Circle for £0.3m
(Sharecast News) - E-commerce investor Huddled Group announced the acquisition of online retailer Food Circle Supermarket on Friday, for total consideration of up to £0.3m.
Bens Creek shares fall as it moves mine into care and maintenance
(Sharecast News) - Shares in North American metallurgical coal miner Bens Creek were sliding on Friday afternoon, after the company issued an update on its operations and working capital position, confirming that its West Virginia mine was moving into care and maintenance.
Premier Miton reports rise in assets under management
(Sharecast News) - Premier Miton Group said in an update on Friday that as of 31 March, its assets under management totalled £10.7bn, making for an increase from the £9.8bn it recorded on 30 September.
Tern raises £0.42m to invest in Wyld Networks
(Sharecast News) - Specialist internet-of-things technology investor Tern announced on Friday that it hs raised £0.42m before expenses, to invest in Wyld Networks.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.